What does HRD status mean for Prostate Cancer treatment
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding HRD Status in Prostate Cancer
HRD stands for Homologous Recombination Deficiency — this refers to a defect in your cancer cells' ability to repair damaged DNA using a specific repair pathway called homologous recombination.
How DNA Repair Relates to Cancer Treatment
Think of DNA repair like a quality control system in cells. Cancer cells accumulate damage over time, and normally they have multiple ways to fix that damage. When cells have HRD, they've lost one of their main repair mechanisms, making them more vulnerable to certain treatments.
Why HRD Status Matters for Prostate Cancer
PARP Inhibitors and HRD: According to the CancerPatientLab webinar on advanced prostate cancer, patients with HRD-positive status (meaning they have DNA repair gene mutations like BRCA) may benefit from PARP inhibitors. PARP inhibitors work by blocking another DNA repair pathway, which forces cancer cells with HRD to accumulate lethal damage and die.
In the webinar, a patient with advanced prostate cancer who had previous genetic testing showing "some efficacy with PARP inhibitors" was exploring this option after other treatments became less effective. This illustrates how HRD status can open up targeted treatment pathways.
What Genes Are Tested?
HRD status typically involves testing for mutations in genes like:
- BRCA1 and BRCA2 (the most common)
- Other DNA repair genes (ATM, CHEK2, PALB2, and others)
Important Questions for Your Oncologist
- Has my tumor been tested for HRD or DNA repair gene mutations? If not, should it be?
- If I have HRD, am I a candidate for PARP inhibitor therapy?
- What other treatment options does my HRD status open up?
- Should I get a Foundation One or similar comprehensive genomic test to identify all relevant mutations?
- Are there clinical trials available for HRD-positive prostate cancer patients?
Important Context
The webinar emphasizes that genetic testing can sometimes face logistical challenges (as one patient experienced with a misdirected sample), so it's worth confirming that your test was processed correctly and that you receive your results.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Prostate Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: